IPLAN RT DOSE 4.1.1
Report
- Report Number
- 8043933-2010-00004
- Event Type
- Malfunction
- Date Received
- March 10, 2010
- Date of Event
- February 8, 2010
- Report Date
- February 9, 2010
- Manufacturer
- BRAINLAB AG
- Product Code
- MUJ
- PMA / PMN Number
- K080888
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THIS USER DID NOT USE THE PLAN FOR PT TREATMENT. THERE HAS BEEN NO PT INJURY REPORTED BY ANY HOSPITAL; HOWEVER, A RISK TO PT HEALTH COULD NOT BE EXCLUDED. BRAINLAB INVESTIGATION HAS SHOWN THAT IPLAN RT DOSE 4.1.1 EXPORTS A TOO HIGH NUMBER OF MONITOR UNITS (MUS) IF ALL OF THE FOLLOWING CONDITIONS ARE MET: THE MULTI LEAF COLLIMATOR TYPE IS SIEMENS 160 MLC AND THE TREATMENT MODALITY IS IMRT AND THE PTV WIDTH IS LARGER THAN 200 MM AND THEREFORE THE IMRT FIELD IS SPLIT INTO SEVERAL "SPLIT-FIELDS" USING THE MLC CARRIAGE MOVEMENTS. BRAINLAB INTENDS THE FOLLOWING CORRECTIVE ACTIONS: POTENTIALLY AFFECTED CUSTOMERS RECEIVE A PRODUCT NOTIFICATION INFO (SEE ATTACHED). POTENTIALLY AFFECTED CUSTOMERS WILL RECEIVE A NEW CONFIGURATION-FILE THAT WILL DISABLE "SPLIT FIELDS" FOR SIEMENS 160 MLC MULTI LEAF COLLIMATORS. TENTATIVELY PLANNED AVAILABILITY: (B)(6) 2010. BRAINLAB WILL ACTIVELY CONTACT POTENTIALLY AFFECTED CUSTOMERS UPON AVAILABILITY TO IMPLEMENT THE ACCORDING NEW CONFIGURATION-FILE. CONCLUSION: THERE HAS BEEN NO PT INJURY REPORTED BY THIS OR ANY OTHER HOSPITAL, HOWEVER A RISK TO PT HEALTH COULD NOT BE EXCLUDED.
AFTER EXPORTING A PLAN CREATED WITH THE BRAINLAB RADIOTHERAPY TREATMENT PLANNING SOFTWARE IPLAN RT DOSE TO THE RECORD & VERIFY SYSTEM, THE USER NOTICED THAT IPLAN RT DOSE EXPORTED A HIGHER NUMBER OF MONITOR UNITS (MUS) FOR PT IRRADIATION THAN INTENDED BY THE TREATMENT PLAN. ACCORDINGLY, THE USER DID NOT USE THE PLAN FOR PT TREATMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | IPLAN RT DOSE 4.1.1 | PLANNING SW, RADIATION THERAPY TREATMENT | MUJ | BRAINLAB AG | 4.1.1 | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |